Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increasing clinical data accuracy, and promoting positive health economics.
Observe Medical is listed on Euronext Oslo under OBSRV.
Oslo, March 23, 2023 – Observe Medical ASA ("Observe Medical" or "the Company") has entered into loan agreements for its short term financing needs. Further to the stock exchange announcement on 14 December 2022, the Company has entered into loan agreements where the lenders have committed to an amount of NOK 10 million. The Company…
Read moreObserve Medical ASA: Fourth quarter 2022 results Oslo, 17 February 2023 – Observe Medical ASA (“the Company” or “Observe Medical”) today releases its results for the fourth quarter of 2022. "The year 2022 has been a transformational year for Observe Medical. Building on the growth initiatives seen earlier in the year, we signed two exclusivity…
Read moreOslo, 14 December 2022 – The Nordic medtech company Observe Medical ASA ("Observe Medical" or "the Company") is planning to issue a NOK 30-50 million bond loan in the first quarter of 2023, which is expected to be followed by a NOK 100-150 million equity issue around mid-year 2023. It is contemplated that the bond…
Read moreAs at 14 March 2023.
| Name | Number of shares | % of top 20 | % of total | Country | ||
|---|---|---|---|---|---|---|
| 1 | INGERØ REITEN INVESTMENT COMPANY AS | 9,653,680 | 29.56% | 18.05% | Norway | |
| 2 | NAVAMEDIC ASA | 4,222,727 | 12.93% | 7.89% | Norway | |
| 3 | RO, LARS | 3,340,000 | 10.23% | 6.24% | Norway | |
| 4 | JPB AS | 2,830,209 | 8.66% | 5.29% | Norway | |
| 5 | ELI AS* | 1,744,260 | 5.34% | 3.26% | Norway | |
| 6 | MP PENSJON PK | 1,676,188 | 5.13% | 3.13% | Norway | |
| 7 | UBS Switzerland AG | 1,460,413 | 4.47% | 2.73% | Switzerland | |
| 8 | BJØRNTVEDT, VEGARD | 809,962 | 2.48% | 1.51% | Norway | |
| 9 | LAPAS AS | 805,185 | 2.47% | 1.51% | Norway | |
| 10 | NORDNET LIVSFORSIKRING AS | 786,471 | 2.41% | 1.47% | Norway | |
| 11 | Nordnet Bank AB | 653,507 | 2.00% | 1.22% | Sweden | |
| 12 | SILVERCOIN INDUSTRIES AS | 624,464 | 1.91% | 1.17% | Norway | |
| 13 | SOLEGLAD INVEST AS | 586,668 | 1.80% | 1.10% | Norway | |
| 14 | SKÅLVOLD EIENDOM AS | 507,513 | 1.55% | 0.95% | Norway | |
| 15 | TAJ HOLDING AS | 500,847 | 1.53% | 0.94% | Norway | |
| 16 | GINNY INVEST AS | 500,000 | 1.53% | 0.93% | Norway | |
| 17 | PETTERSEN, GUNERIUS | 500,000 | 1.53% | 0.93% | Norway | |
| 18 | TRANBERGKOLLEN INVEST AS | 500,000 | 1.53% | 0.93% | Norway | |
| 19 | CAM AS | 481,000 | 1.47% | 0.90% | Norway | |
| 20 | BRØDRENE KARLSEN HOLDING AS | 479,868 | 1.47% | 0.90% | Norway | |
| Total number owned by top 20 | 32,662,962 | 100.00% | 61.06% | |||
| Total number of shares | 53,491,656 |
* Pending transfer to each shareholders VPS account ELI AS has, since the closing af the Biim Ultrasound acquisition in March 2022, held 433,818 shares owned by former shareholders in Biim Ultrasound AS. The transfer of the shares took place on March 14 2023 with the result that ELI’s registered shareholding in Observe Medical have been reduced by the corresponding number of shares.
Stock Exchange:
Ticker:
First day of listing:
Sector:
Trading Currency:
ISIN:
Number of shares issued:
Nominal value:
Euronext Expand Oslo
OBSRV
4 November 2019
Healthcare
NOK
NO0010865009
53 491 656
NOK 0.26
The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bård Brath Ingerø (chair) and Grete Hogstad.
The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these.
For nomination committee please contact:
Bård Brath Ingerø, Chair of the Nomination Committee
+47 92 83 33 34 / bbi@reitenco.no
3 June 2022: Minutes from Annual General Meeting 2022
3 June 2022: Represented list
31 May 2022: Board of Directors recommendation for appointment of auditor
31 May 2022: The Nomination Committee recommendation part 2
13 May 2022: Notice of Annual General Meeting on 3 June 2022
13 May 2022: Notice of attendance and proxy form to the Annual General Meeting on 3 June 2022
13 May 2022: The Nomination Committee’s recommendation (part 1)
13 May 2022: Guidelines for determination of salary and other remuneration to executive personnel
13 May 2022: Report on salary and other remuneration to executive personnel year 2021
13 May 2022: VPS – Investor services
13 May 2022: LUMI
13 May 2022: Online guide LUMI (Norsk)
13 May 2022: Online guide LUMI (English)
4 February 2022: Minutes from Extraordinary General Meeting
4 February 2022: Represented list
14 January 2022: Notice of Extraordinary General Meeting on 4 February 2022
14 January 2022: Notice of attendance and proxy form to the Extraordinary General Meeting on 4 February 2022
21 May 2021: Minutes from Annual General meeting
30 April 2021: Notice of Annual General Meeting on 21 May 2021
30 April 2021: Notice of attendance and proxy form to the Annual General meeting on 21 May 2021
30 April 2021: The Nomination Committee's recommendation
30 April 2021: Guidelines for determination of salary and other remuneration to executive Personnel
30 June 2020: Annual General Meeting
16 June 2020: Extraordinary General Meeting
9 June 2020: Notice of Annual General Meeting on 30 June 2020
9 June 2020: Attendance to the Annual General Meeting on 30 June 2020
9 June 2020: Recommendation by the Nomination Committee
9 June 2020: The Boards declaration on remuneration to executive management
26 May 2020: Notice of Extraordinary General Meeting on 16 June 2020
26 May 2020: Attendance to the Extraordinary General Meeting on 16 June 2020
24 October 2019: Extraordinary General Meeting
1 October 2019: Extraordinary General Meeting
5 August 2019: Extraordinary General Meeting
Rune Nystad, Chief Executive Officer +47 91 62 46 83 / rune.nystad@observemedical.com
Per Arne Nygård, Chief Financial Officer +47 41 10 43 45 / perarne.nygard@observemedical.com